Effects of a combination of varenicline and transdermal nicotine patch on post-quitting urges to smoke - Combination of NRT and varenicline to increase cessation of tobacco
- Conditions
- Tobacco dependence (smoking cessation)
- Registration Number
- EUCTR2010-022334-92-GB
- Lead Sponsor
- Barts and the London School of Medicine and Dentistry, Queen Mary University of London
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Smokers seeking treatment, aged 18 and over, consenting to take part in the trial.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Pregnant or breastfeeding, end-stage renal disease, previous allergic reaction to varenicline or patch, unable to fill in the questionnaire in English or currently taking part in another research study.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method